Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 58Unknown 13Terminated 8Active not recruiting 5Recruiting 4Withdrawn 2Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 1789Neoplasms 1516Carcinoma, Non-Small-Cell Lung 1053Prostatic Neoplasms 965Colorectal Neoplasms 889Lung Neoplasms 809Pancreatic Neoplasms 583Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 540Stomach Neoplasms 523Ovarian Neoplasms 513Neoplasm Metastasis 492Multiple Myeloma 491Recurrence 417Melanoma 390Squamous Cell Carcinoma of Head and Neck 374Uterine Cervical Neoplasms 366Brain Neoplasms 364Head and Neck Neoplasms 355Esophageal Neoplasms 320Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Endometrial Neoplasms 311Lymphoma 309Triple Negative Breast Neoplasms 301Glioblastoma 298Rectal Neoplasms 284Urinary Bladder Neoplasms 268Sarcoma 266Hematologic Neoplasms 266Colonic Neoplasms 257

Interventions

Nutritional Status 1Exercise 1Duloxetine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Neurotoxicity Syndromes × Clear all
NCT07558447 2026-04-30

CHEMOVES

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Phase NA Recruiting
120 enrolled
BreastGastrointestinalGenitourinaryHead & NeckThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Neoplasms, Urologic Neoplasms, Neurotoxicity Syndromes

NCT07173166 2026-03-10

CARE-T

Instituto de Investigacion Sanitaria INCLIVA

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Motor Activity, Hematologic Neoplasms, Neurotoxicity Syndromes

NCT07357636 2026-01-28

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors

Shantou University Medical College

Recruiting
940 enrolled

Neurotoxicity Syndromes

NCT06551051 2024-09-19

ADC-induced Neurotoxicity Treated With Duloxetine

Fudan University

Phase 2 Recruiting
37 enrolled

Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡